Medicilon CMC Sector – Process Department

Fill out the form below to download this content.
Medicilon Flow Cytometry Technology Platform

Fill out the form below to download this content.
Medicilon NanoString nCounter Detection Platform

Fill out the form below to download this content.
Medicilon Single B Cell Antibody Discovery Technology Platform

Fill out the form below to download this content.
Medicilon Enzyme Catalytic Platform

Fill out the form below to download this content.
Medicilon Cell & Gene Therapy R&D Service Platform

Fill out the form below to download this content.
Medicilon Antibody R&D Service Platform

Fill out the form below to download this content.
Medicilon ADC R&D Service Platform

Fill out the form below to download this content.
7th Anniversary Q&A 5: How to Break Global Regulatory Barriers and Achieve One Single Study for Multi‑Country IND Filings?
Chinese innovative drugs are moving quickly toward globally synchronized development, multi-country IND filings, and out‑licensing. But regulatory standards diverge, GLP requirements, animal welfare rules, and data formats differ significantly across markets: leaving companies in a bind: repeat the studies and pay in cost and time, or reuse existing data and risk deficiency letters, or outright […]
7th Anniversary Q&A 4: From Isolated Capabilities to a Symbiotic Ecosystem — How Is Medicilon Building a New Drug Innovation Ecosystem?
How can new drug candidates clear R&D hurdles and advance from lab concepts to clinical trials? Seven years after its STAR Market listing, Medicilon delivers a CRO answer: stepping beyond isolated service nodes to build an open, evolving innovation ecosystem that unites original research, translational maturation, capital support, AI enablement, talent development and client collaboration. […]